key: cord-0984430-6tx39p56
authors: Golubovskaya, Vita; Bukrinsky, Michael I; Grizzi, Fabio
title: Editorial On “Exosomes, Their Biogenesis and Role in Inter-Cellular Communication, Tumor Microenvironment and Cancer Immunotherapy”
date: 2020-07-28
journal: Vaccines (Basel)
DOI: 10.3390/vaccines8030421
sha: 3dda5436cfa1f58cfa83c91bbb0ec51c58e741af
doc_id: 984430
cord_uid: 6tx39p56

The term "Exosomes" defines small extracellular vesicles, ranging from 30 to 150 nm in diameter, secreted by most eukaryotic cells into surrounding body fluids including blood, saliva, urine, bile and breast milk [...].

and targeting them to cancer cells. Exosomes from dendritic cells pulsed with peptides were able to stimulate and activate T-lymphocytes against tumors [7] . The review by Kishore Kumar Jella et al. "Exosomes, Their Biogenesis and Role in Inter-Cellular Communication, Tumor Microenvironment and Cancer Immunotherapy" highlighted an important role of exosomes in cancer and immunotherapy [4] . It has also discussed the role of these vesicles in cell-cell communication between various cell populations through several proposed mechanisms, such as binding to the surface of recipient cells, fusion of vesicles after their adhesion, receptor mediated endocytosis, and phagocytosis, in a wide range of physiological and pathological processes. The exosomes produced by cancer cells play an important role in cancer-related events such as angiogenesis, metastasis, and regulation of the tumor microenvironment [5] . These vesicles also affect cells of the immune system by inhibiting NK-cells, CD4 + and CD8 + lymphocyte proliferation, thus blocking the anti-tumor immune cell functions [5] . Tucci et al. [6] have also shown a correlation between high levels of CD28 and programmed death receptor 1 (PD-1) in exosomes and the therapeutic response to anti-CTLA4 immunotherapy in metastatic melanoma. On the other hand, exosomes can be used for anti-cancer immunotherapy by loading them with immunotherapy drugs and immunostimulants and targeting them to cancer cells. Exosomes from dendritic cells pulsed with peptides were able to stimulate and activate T-lymphocytes against tumors [7] .

However, cancer is only one of many diseases where exosomes are important pathogenic factors but can also be used therapeutically. Conjugating the lysosomes with antibody recognizing the antigen expressed in the tissue affected by the autoimmune disease, and loading them with an immunosuppressive therapeutic agent, may provide an effective treatment for autoimmune diseases, such as rheumatoid arthritis, by delivering the therapy directly to affected tissues. A potential protective role of exosomes has been also reported in progressively debilitating neurodegenerative conditions that lead to motor and cognitive dysfunction, such as Parkinson disease [8] . The same concept may be used for treating infectious diseases, including the current pandemic of COVID-19. Here, using exosomes coated with an antibody to Angiotensin-converting enzyme 2 (ACE2), a receptor to SARS-CoV-2, and loading them with antiviral drug, such as remdesivir, would deliver the drug to cells targeted by the virus, thus greatly reducing the side effects. Exosomes are major players in viral pathogenesis. For example, the effect of Human Immunodeficiency Virus (HIV) infection on cholesterol metabolism, the key event in pathogenesis of several HIV-associated co- However, cancer is only one of many diseases where exosomes are important pathogenic factors but can also be used therapeutically. Conjugating the exosomes with antibody recognizing the antigen expressed in the tissue affected by the autoimmune disease, and loading them with an immunosuppressive therapeutic agent, may provide an effective treatment for autoimmune diseases, such as rheumatoid arthritis, by delivering the therapy directly to affected tissues. A potential protective role of exosomes has been also reported in progressively debilitating neurodegenerative conditions that lead to motor and cognitive dysfunction, such as Parkinson disease [8] . The same concept may be used for treating infectious diseases, including the current pandemic of COVID-19. Here, using exosomes coated with an antibody to Angiotensin-converting enzyme 2 (ACE2), a receptor to SARS-CoV-2, and loading them with antiviral drug, such as remdesivir, would deliver the drug to cells targeted by the virus, thus greatly reducing the side effects. Exosomes are major players in viral pathogenesis. For example, the effect of Human Immunodeficiency Virus (HIV) infection on cholesterol metabolism, the key event in pathogenesis of several HIV-associated co-morbidities, is mediated to a large extent by exosomes carrying the viral protein Nef [9] . Exosomes released from cells infected with such viruses as HIV, Hepatitis C Virus (HCV), human T-cell lymphotropic virus (HTLV), and Dengue Virus (DENV) harbor and deliver many regulatory factors, including viral RNA and proteins, viral and cellular miRNAs, and other host functional genetic elements to neighboring cells, helping to establish productive infections and modulating anti-viral cellular responses [10] . Therefore, targeting exosomes carrying pathogenic viral factors is another, yet unexplored, therapeutic strategy.

An acknowledged advantage of exosomes is their size in the nano range and the fact that they are shed by both natural and abnormal cells, and therefore can be isolated from the host's own cells [4] . However, studies of body fluid-derived exosomes still remain a challenge, since the isolated exosomes are derived from many different cell types and contain components of body fluids ("contaminants"), which have to be removed during exosome isolation. The utility of exosomes as disease markers is challenged by multiple factors that can influence exosome production and properties. For example, hypoxia has been reported as an important environmental factor that affects exosome production [11] . The field of exosomal research is rapidly advancing, but recent technological progress in exosome isolation and their analysis has not yet led to a universally accepted recommendation for exosome isolation [12] . Additionally, approaches to data acquisition/analysis vary widely and need unification.

Exosomes can play an important role in the diagnostics of cancer as a biomarker, in infectious diseases as a target of therapeutic interventions, in vaccine development and anti-viral therapy as a delivery vehicle (Figure 1) . Future studies will be important to reveal the detailed molecular mechanisms of the biological and immunological functions of exosomes. 

Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: Selective externalization of the receptor

Transferrin recycling in reticulocytes: pH and iron are important determinants of ligand binding and processing

Exosome-based Tumor Therapy: Opportunities and Challenges

Their Biogenesis and Role in Inter-Cellular Communication

Modifying the tumour microenvironment and reverting tumour cells: New strategies for treating malignant tumours

Exosomes in melanoma: A role in tumor progression, metastasis and impaired immune system activity

Alarmin-painted exosomes elicit persistent antitumor immunity in large established tumors in mice

Exosomes derived from mesenchymal stem cells repair a Parkinson's disease model by inducing autophagy

Exosomes containing HIV protein Nef reorganize lipid rafts potentiating inflammatory response in bystander cells

Exosomes and Their Role in the Life Cycle and Pathogenesis of RNA Viruses

Optimization of cell culture conditions for exosome isolation using mini-size exclusion chromatography (mini-SEC)

Optimized exosome isolation protocol for cell culture supernatant and human plasma

Funding: This research received no external funding.

The authors declare no conflict of interest.